# Trial on Single/Multiple Ascending Doses for Safety, PK and PD for CBP-0276 in Healthy Subjects

> **NCT07708831** · PHASE1 · COMPLETED · sponsor: **Clarent Biopharma, Inc.** · enrollment: 64 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** CBP-0276 Acetate
- **DRUG:** Placebo for CBP-0276 Acetate

## Key facts

- **NCT ID:** NCT07708831
- **Lead sponsor:** Clarent Biopharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-04
- **Primary completion:** 2026-02-16
- **Final completion:** 2026-04-30
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07708831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07708831, "Trial on Single/Multiple Ascending Doses for Safety, PK and PD for CBP-0276 in Healthy Subjects". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07708831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*